drugset / Trial / NCT00252226

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

NCT00252226

Non-randomizedFactorialOpen-labelTreatment

Summary

This is a single center, open prospective study to evaluate the effectiveness of quetiapine monotherapy in the maintenance treatment of adolescent patients with a bipolar spectrum disorder (bipolar I and bipolar II disorders, cyclothymia, and bipolar disorder not otherwise specified \[bipolar NOS\]) for a minimum of 48 weeks. Patients will be screened (enrolment phase) either when already stabilized or during an acute episode of mania/hypomania or depression.

Timeline

Start
2004-06
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications